ALK and cancer: This finding is substantiated by Nouri et al. who elucidated the Hippo pathway effector, yes-associated protein, and transcriptional co-activator with PDZ-binding motif (YAP/TAZ) is critical in mediating anaplastic lymphoma kinase (ALK)-induced up-regulation of PD-L1 in multiple cancer cell lines.